Furthermore, cardiac‐specific overexpression of CTRP9 decreased cardiomyocyte size, cardiac fibrosis, and the cardiac contents of α‐SMA, TGF‐β, and β‐MHC in mice with established MI (Figure 4G–I). This evidence concerns the gene C1QTNF9 and myocardial infarction.